Global Pharmatech Establishes Joint Scientific Research Entity With Changchun Center

July 25, 2005 | Print | Email Email | Comments | Category: News


    Global Pharmatech announced that its wholly-owned subsidiary, Jilin Natural Pharmatech Group Co. Ltd., has established a joint scientific research entity, named Changchun Traditional Chinese Medicine (TCM) Technology Service Company, Ltd., with Changchun Science and Technology Enterprise Service Center, one of the divisions of the government's Changchun High-Tech Development Area.

    Jilin Natural Pharmatech and Changchun Science and Technology Enterprise Service Center will work towards establishing a technology platform for research and development (R&D) of modernized TCM products under this joint
    research entity.

    This entity, Changchun TCM Technology Service Company, will receive local government support and funding. One of the main goals of Changchun TCM Technology Service Company will be to help companies discover and develop TCM based drug products in addition to supporting large-scale, government-supported herbal drug development projects within these other companies.


    Rate this page: 1 Star2 Stars3 Stars4 Stars5 Stars

    Loading ... Loading ...
    Related News:
  • Monsanto Expands Chinese Education Sponsorship
  • China's First Wind Energy Research Center Targets Hebei
  • China And U.S. Form Clean Energy Joint Research Center
  • Merieux Co-establishes HIV/AIDS Research Fund With Nanjing U
  • Train Collision Kills 6 In NE China
  • China And Australia Initiate International Light Alloy Research Center
  • Forum In HK to Promote Fight Against Cancer
  • Spreadtrum Helps Peking University With New Laboratory
  • Coca-Cola Opens Chinese Medicine Research Center
  • Novartis Creates Strategic Biomedical R&D Center In Shanghai



    • Leave A Comment:



    Inside ChinaCSR.com